2023-03-31-accounts - Sussex Cancer Fund

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

BJ Tremlett	Chair)
RA Leeds (Honorary	Treasurer)	Resigned	20/02/2023
R G Maxwell		Resigned	20/02/2023
W H T Fenton		Resigned	26/04/2023
F R Sims
R H Taylor
S D Crocker		Appointed	20/02/2023
N Pearce		Appointed	20/02/2023

Sussex Cancer Fund mited by Guarantee Auditor's report (continued) For the Year Endtd 31 March 2023 A further descriptyon of our responsibilitye5 for the audit of the ffinanclal statements is locaod on th¢ Financial Reporung Cttuncll's web51te aL hccpsJlwww.frc.org.uklOur-WorklAUdidAuditnd.asSUrlnCetsndard5-?nd.gUld8ncelst8dard$Ind. guidance-for4udltttrslAuditors-responsibitsoes-for-auditlDescriptioTh-of-auditor5-re5ponsibilities-for-3udiaspx. Thls de5criptlgn fwms part of our auditor's reporL Extsnt to which thtr Ltdit was considered capable of detectlng Irregularitles. Includlng frxud The obj¥tives of our audi( In respect to frdud, arÈ'. eo identify and 35sess the risks of Material misstatement of the financial staternerbts due w fraud- to obtain $ufficien¢ appropriate audit evidente reEarding the 2sse35ed risks of Material mis$otement due to fraud. through designing and implemeniing appropriate responses.. and to respond appropriately to fraud or suspetted fraud identifiEd during the audit. However. the primary responsibility for the preventyon and detettion of fraud rests with both those charged with governance of the entity ind its tnawernenr. Our approach w35 3$ follows.. We identsfied areas of hw5 anrj r¢gulation5 that couhl reasonably be expetted to have a material effttt on thè financial statements from our general sector experience, and through dixu55i9n with the tnJstees and other management {as required by authting standards), and discussed the trustees and other managernent (he policies and procedures regarding compliance with laws and regulations Isee below),. We identtfied the following areas as those most likely tts have such an effect.. heakh 3nd safety., GeDeral Da(a Pmtection Regulation IGDPR)." fraud: bribery and corruption, and employtnent law. Auditing ttandards limit the required ath"c proeedurès tg identify non-compliance these laws and regulations to tftqulry of the trustees and other rnanement and inspection of regulatory and lepl correspotsdeneè, rf any. The identified acwal or suspected non-tompliance wa5 ngt 5uffi¢iently significant to our audit to result in our response bein£ idoncifiod as a key audit matter.. We con5idErEd the legal ad regulatory frameworks directty applicable to the financial starements repotting framework IFRS 102, the Companle5 Act 2006 and the ChariEIES ACE 201113nd the relevant tax compliance regukdtlons in the UK. We consldered the nature of the charlty'5 operadon the eontrol environment and financial perforrnahce. We comThunic3ted identified laws and regularions throughout our team 2nd remain¢d alerr to any indicat49n5 of non<ompliance throughout the audit., We considÈred the procedures and contro15 that the charity ha5 e5È2blished to addres5 risks identrfied. or that otherwiso prevenk deter and dÈthct fi7ud.' and how senior management monitor5 those programmes and confrols. Page 11 of 25

			Unrestricted	Restricted	Total	Total
			funds	funds	2023	2022
		Notes			6	6
Income (romi
Donations and legacies			248,890	56,736	305,625	391,328
Investment income			11,929	0	11,929	5,311
Total income			260,819	56,736	317,555	396,639
Expenditure on:
Raising funds			(3,323)	0	(3,323)	(3,046)
Charitable activities			(146,515)	(15,188)	(161,703)	(350,138)
Total expenditure			(149,838)	(15,188)	(165,026)	(353,184)
Net gains/(losses) on investments		12	(13,100)	0	(13,100)	47,780
Net income/(expenditure)			97,881	41,548	139,429	91,235
Transfers between	funds	18	(70,029)	70,029	0	0
Net movement in funds			27,852	111,577	139,429	91,235
Reconciliation offunds
Total funds brought	forward		816,283	1,884	818,167	726,932
Total funds carried forward			844,135	113,461	957,596	818,167

							2023	2022
						Notes
Fixed assets								Restated
Investments						12	545,348	558,448
Current assets
Debtors						13	38,500	125,145
Cash at bank and			in hand				819,893	764,351
							858,393	889,496
Creditors:	amounts			falling due within one year		14	(287,665)	(311,481)
Net current		assets					570,728	578,015
Total assets		less current			liabilities		1,116,076	1,136,463
Creditors:	amounts			falling due after more than one year		15	(158,480)	(318,296)
Net assets							957,596	818,167
The funds	ofthe		Trust:
Restricted	funds					18	113,461	1,884
Unrestricted		funds				18	844,135	816,283
							957,596	818,167

For the Year Ended	31 March 2023
							2023	2022
				Notes
Cash flows from operating activities: Net income/expenditure for the year							139,429	91,235
Unreahsed (gain)/losses Dividends and interest	on investments from investments			12			13,100 (11,929)	(47,780) (5,311)
(Increase)/decrease in Increase/(decrease) in	debtors creditors			13 14			86,645 (183,632)	(106,937) 72,189
Net cash provided	by/(used in) operating	activities					43,613	3,396
Cash flows from investing activities:
Dividends and interest	from investments						11,929	5,311
Increase/(decrease)	in cash						55,542	8,707
Cash and cash equivalents at the beginning			ofthe year				764,351	755,644
Cash and cash equivalents at the end of		the	year				819,893	764,351
Analysis of cash and cash equivalents					At	I April	Cash flow	At 31
						2022		March
								2023
								6
Cash at bank and in	hand				764,351		55,542	819,893

			Unrestricted	Restricted	Total
			funds	funds	2022
Income from:			fs	fs	fs
				Restated
Donations and legacies			391,328		391,328
Other trading activities:
Fundraising					0
Investment income			5,3 I I		5,311
Total income			396,639	0	396,639
Expenditure on:
Raising funds:
Fundraising			(3,046)	0	(3,046)
Chantable activities			(189,852)	(160,286)	(350,138)
Total expenditure			(192,898)	(160,286)	(353,184)
Net gains/(losses) on investments			47,780	0	47,780
Net income/(expenditure)			251,521	(160,286)	91,235
Transfers between	funds		(100,000)	100,000	0
Net movement in funds			151,521	(60,286)	91,235
Reconciliation of	funds
Total funds brought	forward		664,762	62,170	726,932
Total funds carried forward			816,283	1,884	818,167
Income from donations		and legacies
				2023	2022
				6	6
Donations and gifts				289,797	166,841
Legaoes receivable				15,829	224,487
				305,625	391,328
Investment income
				2023	2022
				6
Interest receivable				11,929	5,311

Expenditure
		Staff	Ocher	Grant	Total	Total
		cosTs	cos'ts	funding	2023	2022
					6	6
Raising funds
Fundraising			3,323		3,323	3,046
Charitable activities
Donation to the Macmillan	Cancer		0	61,089	61,089	55,942
Funding services for the direct			53,824	0	53,824	72,474
benefit of patients Funding cancer research projects				(52,047)	(52,047)	160,286
Funding of cancer speciahst				23,644	23,644	0
equipment Support expenditure		52,865	22,327		75,192	61,436
		52,865	76,151	32,686	161,703	350,138
Total expenditure		52,865	79,474	32,686	165,026	353,184

Analysis o	fsupport costs (including Governance cos	ts)
		2023	2022
		6	6
Wages and	salaries	52,865	49,951
General office and administration		14,227	3,685
Governance	costs:
Audit fees		8,100	7,800
		75,192	61,436

Grants payable
					2023	2022
						6
Net surplus for the		year	is	stated after charging/(crediting):
Research grants					(52,047)	160,286
Equipment grants					23,644
					(28,403)	160,286
Net grants awarded		during		the year	0	160,286
Grants previously	awarded			which are no longer required	(52,047)	0
					(52,047)	160,286

				2023	2022
				Number	Number
Admimstration		and support	staff	2	2
Employment		costs		2023	2022
Wages	and social security		costs	49,814	47,100
Pension	contributions			3,051	2,851
				52,865	49,951

12	Fixed asset	investments	investments	investments
									E
	Fair value at	I April 2022							558,448
	Change m value		in the year						(13,100)
	Fair value at	31	March 2023						545,348
	Iffixed assets had not been revalued,				they would	have been included	at the following	historical cost:
								2023	2022
								E	E
	Cost							450,000	450,000
13	Debtors							2023	2022
								E	E
	Income tax	recoverable						10,000	10,145
	Prepayments	and accrued incoine						28,500	115,000
								38,500	125,145
14	Creditors:	amounts		falling due	within one year			2023	2022
	Grants payable							208 476	298,888
	Trade creditors							10,000	4,793
	Accruals							69,189	7,800
								287,665	311,481
15	Creditors:	amounts		falling due	after more	than one year		2023	2022
								E	E
	Grants payable		1-2years					158,480	318,296
								158,480	318,296
16	Pension and		other post-retirement benefit commitments
	Defined contribution
								2023	2022
								E	f
	Contributions		payable	by the Trust	for the year			3,051	2,850

				2023	2022
				6
Research grants	brought forward			617,184	549,121
Net commitments/(withdrawals)			made during the year	(52,047)	160,286
Research grants	paid during	rhe year		(198,181)	(92,023)
Commitments	at 31 March	2023		366,956	617,384
Commitments	at 31 March	2023	are payable as follows:
Withm one year				208,476	298,888
After more than one year				158,480	318,296
				366,956	617,184

					Movement in funds	Movement in funds
								Balance
			Balance at April 2022	I	Income	Expenditure	Transfers	at 31 March
								2023
								6
			Restated
Restricted	funds		1,884		56,736	(15,188)	70,029	113,461
Unrestricted		funds
Protected reserve			450,000		0	0	(300,000)	150,000
Designated	funds				0	0	342,304	342,304
Undesignated		funds	366283		260819	(162938)	(112,333)	351,831
			816,283		260,819	(162,938)	(70,029)	844,135
Total funds			818,167		317,555	(178,126)	0	957,596

Analysis ofrestricted	funds at 31 March 2023	funds at 31 March 2023	funds at 31 March 2023
Book Fund - provision	ofcancer related literature					493
Breast Cushions - provision of equipment						3,117
Chemotherapy Nurses	- support for NHS	staff				812
Haemotology - support	for haemotology	related research				42,964
Equipment						12,500
Haemotology - support	for haemotology	related research				27
Head, Neck fk Thyroid	service support					116
Thancs - support for local cancer related		charity affiliate				248
Website development	including cancer related		literature			325
Whizz It Up - provision	of cancer related	literature				759
Worthing Breast Care	- support for Worthmg		Hospital	breast cancer services		52,100
						113,461
Analysis ofnet assets between funds
				Unrestricted	Restaicted	Total
				6		6
Fund balances at 31 March 2023 are		represented		by:
Investments				545,348	0	545,348
Current assets				744,932	113,461	858,393
Creditors: amounts falling due within one year				(287,665)	0	(287,665)
Creditors: amounts falling due after more than			one year	(158,480)	0	(158,480)
				844,135	113,461	957,596

Analysis of net asset	s betw	een funds	- Compara	tive (Restated)
					Unrestricted	Restricted	Total
Fund balances at 31	March	2022 are	represented	by:
Investments					558,448	0	558,448
Current assets					887,612	1,884	889,496
Creditors: amounts	falhng	due within	one year		(3 11,481)	0	(311,481)
Creditors: amounts	falling	due after	more than	one year	(3 18,296)	0	(3 1 8,296)
					816,283	1,884	818,167